IX Biopharma's CBD Wafer Shows Promise for Kidney Failure Symptoms
IX Biopharma Issues 115 Million Rights Shares, 57.5 Million Warrants
IX Biopharma Expands Capital With New Shares and Warrants
Singapore Shares Track Global Losses to End Week in Red; GRP Shares Climb 3%
IX Biopharma Raises SG$3.3 Million From Rights Cum Warrants Issue
IX Biopharma Ltd Faces Rights Issue Shortfall
IX Biopharma's Sublingual NAD+ Wafers Show Promising Results in Human Trial
IX Biopharma's Trial Boosts NAD+ and Wellness
IX Biopharma Advances Rights Cum Warrants Issue
Ix Biopharma Cuts Conversion Price of 9% Convertible Bonds
Singapore Shares Fall As Federal Interest Rate Cut Hopes Dim; China Mining Up 29%
IX Biopharma to Raise Up to SG$5 Million From Rights Issue
IX Biopharma Advances in Drug Development
Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer
IX Biopharma Targets Diabetes With New Wafer
Singapore Stocks Linger in Red; IX Biopharma's Shares Soar 12% Following Unveiling of Novel Drug Delivery System
IX Biopharma Unveils Novel Drug Delivery System; Shares Surge 12%
Singapore Stocks Open on Monday in Red; IX Biopharma's Stock Plunge 9% Following Contract Termination
IX Biopharma's Subsidiary Issues Termination Notice for Licensing Agreement; Shares Plunge 9%
IX Biopharma Stays in Red in Fiscal H1
No Data